New Cancer Diagnosis
نویسندگان
چکیده
منابع مشابه
Can Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?
Introduction: As a glycoprotein, Plasma Prostate-Specific Antigen (PSA) is mainly produced by prostate epithelial cells and is used as a major diagnostic tool for prostate cancer. A group of researchers relate the elevated number of estrogen receptors in breast cancer samples to the over-production of PSA in this type of cancer. Therefore, the present study aimed to determine the participants' ...
متن کاملGene assembling: a new approach in molecular diagnosis of hereditary breast cancer
Abstract Background: Many disease susceptibility genes are large and consist of many exons in which point mutations are scattered throughout. Scanning each exon individually represents a tedious task which can be time consuming and expensive. There has been increasing demand for rapid and accurate methods for full scanning of unknown point mutations in large multi-exon genes. Gene Assembling i...
متن کاملGenetic diagnosis of cancer: diagnosis of mutations in BRCA1 and BRCA2 in breast cancer
During the last two decays the tremendous success in molecular biology and genetics which has surprised the entire world. So that today the sequencing of whole genome has been possible for each human individual to estimate its being affected with cardiovascular and cancer diseases. However, these achievements have some important limitations and deep ethical issues which might be ignored. Geneti...
متن کاملWhat’s New in Cancer Diagnosis and Therapy
The Animal Cancer Care and Research Program (ACCR) was established at the University of Minnesota College of Veterinary Medicine (CVM) in 2007. This program is built as a partnership between the CVM and the Masonic Cancer Center, University of Minnesota to devote the necessary resources to reduce the burden caused by cancer in companion animals and humans alike. The ACCR includes more than 50 f...
متن کاملNew serum biomarkers for prostate cancer diagnosis.
BACKGROUND Prostate-specific antigen (PSA) is currently used as a biomarker for diagnosis and management of prostate cancer (CaP). However, PSA typically lacks the sensitivity and specificity desired of a diagnostic marker. OBJECTIVE The goal of this study was to identify an additional biomarker or a panel of biomarkers that is more sensitive and specific than PSA in differentiating benign ve...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: CA: A Cancer Journal for Clinicians
سال: 1973
ISSN: 0007-9235
DOI: 10.3322/canjclin.23.3.174